Legal Representation
Attorney
Howard J. Shire
USPTO Deadlines
Application History
38 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 14, 2012 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| May 14, 2012 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 15, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 14, 2011 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Oct 12, 2011 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Oct 13, 2011 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 12, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Mar 9, 2011 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Mar 7, 2011 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Mar 7, 2011 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Mar 7, 2011 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 12, 2010 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 17, 2010 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 17, 2010 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 9, 2010 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jul 8, 2010 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 9, 2010 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 9, 2010 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 9, 2010 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 9, 2010 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 5, 2010 | DMCC | I | DATA MODIFICATION COMPLETED | Loading... |
| Jun 3, 2010 | ALIE | A | ASSIGNED TO LIE | Loading... |
| May 27, 2010 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 27, 2010 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 27, 2010 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Apr 27, 2010 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Apr 27, 2010 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Apr 27, 2010 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Apr 14, 2010 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 14, 2010 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 14, 2010 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 20, 2009 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 20, 2009 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 20, 2009 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 20, 2009 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 22, 2009 | MPMK | O | NOTICE OF PSEUDO MARK MAILED | Loading... |
| Jul 21, 2009 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 21, 2009 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceuticals and Medicinal preparations, namely, opium alkaloid preparations; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive-cold preparations; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint disease; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelmintics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; preparation for the relief of pain
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005